Preferential prescribing of linagliptin in type 2 diabetes patients in an expanded post‐marketing surveillance study in Japan

AIMS/INTRODUCTION: To evaluate linagliptin prescribing in type 2 diabetes mellitus patients with different comorbidities, an expanded Japanese post‐marketing surveillance also collected baseline data for patients initiating other glucose‐lowering drugs. MATERIALS AND METHODS: Patients initiating lin...

Descripción completa

Detalles Bibliográficos
Autores principales: Fazeli Farsani, Soulmaz, Taniguchi, Atsushi, Ikeda, Rie, Brodovicz, Kimberly G, Bartels, Dorothee B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717825/
https://www.ncbi.nlm.nih.gov/pubmed/30667173
http://dx.doi.org/10.1111/jdi.13012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717825/
https://www.ncbi.nlm.nih.gov/pubmed/30667173
http://dx.doi.org/10.1111/jdi.13012

Ejemplares similares